222 related articles for article (PubMed ID: 17146999)
1. The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.
Rogers DF
COPD; 2005 Sep; 2(3):341-53. PubMed ID: 17146999
[TBL] [Abstract][Full Text] [Related]
2. Treatment of airway mucus hypersecretion.
Rogers DF; Barnes PJ
Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
[TBL] [Abstract][Full Text] [Related]
3. Emerging mucus regulating drugs in inflammatory and allergic lung disease.
Hauber HP; Zabel P
Inflamm Allergy Drug Targets; 2008 Mar; 7(1):30-4. PubMed ID: 18473898
[TBL] [Abstract][Full Text] [Related]
4. Current and future therapies for airway mucus hypersecretion.
Barnes PJ
Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
[TBL] [Abstract][Full Text] [Related]
5. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.
Rogers DF
Monaldi Arch Chest Dis; 2000 Aug; 55(4):324-32. PubMed ID: 11057087
[TBL] [Abstract][Full Text] [Related]
6. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
Lai H; Rogers DF
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
[TBL] [Abstract][Full Text] [Related]
7. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
Rogers DF
Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
[TBL] [Abstract][Full Text] [Related]
8. Airway mucus hypersecretion in asthma: an undervalued pathology?
Rogers DF
Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
[TBL] [Abstract][Full Text] [Related]
9. The airway goblet cell.
Rogers DF
Int J Biochem Cell Biol; 2003 Jan; 35(1):1-6. PubMed ID: 12467641
[TBL] [Abstract][Full Text] [Related]
10. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
11. Role of neutrophils in mucus hypersecretion in COPD and implications for therapy.
Kim S; Nadel JA
Treat Respir Med; 2004; 3(3):147-59. PubMed ID: 15219174
[TBL] [Abstract][Full Text] [Related]
12. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD.
Tagaya E; Yagi O; Sato A; Arimura K; Takeyama K; Kondo M; Tamaoki J
Pulm Pharmacol Ther; 2016 Aug; 39():81-4. PubMed ID: 27350218
[TBL] [Abstract][Full Text] [Related]
13. Clinical issues of mucus accumulation in COPD.
Ramos FL; Krahnke JS; Kim V
Int J Chron Obstruct Pulmon Dis; 2014; 9():139-50. PubMed ID: 24493923
[TBL] [Abstract][Full Text] [Related]
14. Airway mucus: the good, the bad, the sticky.
Evans CM; Koo JS
Pharmacol Ther; 2009 Mar; 121(3):332-48. PubMed ID: 19059283
[TBL] [Abstract][Full Text] [Related]
15. Targeting mucus hypersecretion: new therapeutic opportunities for COPD?
Martin C; Frija-Masson J; Burgel PR
Drugs; 2014 Jul; 74(10):1073-89. PubMed ID: 24890395
[TBL] [Abstract][Full Text] [Related]
16. Novel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases.
Ha EV; Rogers DF
Pharmacology; 2016; 97(1-2):84-100. PubMed ID: 26674354
[TBL] [Abstract][Full Text] [Related]
17. Pinellia ternata Attenuates Mucus Secretion and Airway Inflammation after Inhaled Corticosteroid Withdrawal in COPD Rats.
Du W; Su J; Ye D; Wang Y; Huang Q; Gong X
Am J Chin Med; 2016; 44(5):1027-41. PubMed ID: 27430907
[TBL] [Abstract][Full Text] [Related]
18. The role of airway secretions in COPD--clinical applications.
Henke MO; Shah SA; Rubin BK
COPD; 2005 Sep; 2(3):377-90. PubMed ID: 17147002
[TBL] [Abstract][Full Text] [Related]
19. Mucus hypersecretion in chronic obstructive pulmonary disease.
Rogers DF
Novartis Found Symp; 2001; 234():65-77; discussion 77-83. PubMed ID: 11199104
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
